AVEO Pharmaceuticals, Inc. Message Board
-
Astellas is due to file to the EMA in second half of 2013
- Reply to
Firesale prices...this company is not going bankrupt!
by wanna_million •Apr 30, 2013 10:34 AMAstellas is also filing the EMA appiication (SECOND HALF 2013) that may be the wild card, since the trial was conducted in Europe
-
ny thoughts on this, when is the ema making a decision?
-
I am really puzzled how negative the sentiment is.... while volume has picked up, it seems that the market is scared and has little faith in TIVO.... biotechs have been up and yet AVEO is stuck under $7.50. I imagine that with a positive ODAC review the stock will shoot up to $12-13....perhaps even $14? what is everyone else expecting with positive ODAC?
-
check INCY
-
May be positive for GERN....
-
a date (panel review) has been set for may 7, so yeah
-
this should give us confidence that they are going some good progress, especially with biomarjkers and BATON studies for RCC and TNBC... google the following:
"Will biomarkers revolutionise treatment with tivozanib?" published by Pharma Strategy Blog on feb 25, 2013 -
Hey Long
thanks once again for you insight and into CLDX and you deatiled pespective about where we are heading and why.
I have seen some of you posts on LGND board. Are CLDX and LGND you top biotech picks? it seems that LGND will be steadily increasing revenues while mor eoand more of the partnered programs are marketed, Krypolis being one of the most promising ones.
Thanks
S -
EOM
-
almost the entire float traded... and 88% held by institutions... what does this say?
- Reply to
We are not the only bio stock with this kind of move today
by raysfrom98 •Mar 1, 2013 12:39 PMAnother one that is up big is NSPH, does anybody follow that one?